A model for harmonizing flow cytometry in clinical trials

Nat Immunol. 2010 Nov;11(11):975-8. doi: 10.1038/ni1110-975.

Abstract

Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.

MeSH terms

  • Clinical Trials as Topic
  • Flow Cytometry / methods*
  • Flow Cytometry / standards*
  • Humans
  • Specimen Handling